Modulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract

Virulence

Volumn 4, Issue 4, 2013, Pages 315-323

  Foster, Debora Barnett ^a  

^a RYERSON UNIVERSITY   (Canada)

Author keywords

Colonization; Enterohemorrhagic E. coli (EHEC); Environment; Gastrointestinal tract; Virulence

Indexed keywords

ADRENALIN; ETHANOLAMINE; HORMONE; NORADRENALIN; OXYGEN; VIRULENCE FACTOR;

ACIDITY; ANTIGEN EXPRESSION; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BILE; CONCEPTUAL FRAMEWORK; ENTEROHEMORRHAGIC ESCHERICHIA COLI; GASTROINTESTINAL TRACT; HUMAN; LARGE INTESTINE; METABOLITE; MICROBIAL FLORA METABOLITE; MICROENVIRONMENT; MODULATION; NONHUMAN; OXYGEN TISSUE LEVEL; PH; REVIEW;

EID: 84878102930     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.24318     Document Type: Review

References (133)

1. Karmali MA. Infection by Shiga toxin-producing Escherichia coli: an overview. Mol Biotechnol 2004; 26:117-22; PMID:14764937; http://dx.doi.org/10.1385/MB:26:2:117
2. Nataro J P, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11:142-201; PMID:9457432
3. Karmali MA, Mascarenhas M, Shen S, Ziebell K, Johnson S, Reid-Smith R, et al. Association of genomic O island 122 of Escherichia coli EDL 933 with verocy-totoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol 2003; 41:4930-4940; PMID:14605120; http://dx.doi.org/10.1128/JCM.41.11.4930-4940.2003
4. Banatvala N, Griffin PM, Greene KD, Barrett TJ, Bibb W F, Green JH, et al.; Hemolytic Uremic Syndrome Study Collaborators. The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epide-miologic findings. J Infect Dis 2001; 183:1063-1070; PMID:11237831; http://dx.doi.org/10.1086/319269
5. Coombes BK, Wickham ME, Mascarenhas M, Gruenheid S, Finlay BB, Karmali MA. Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains. Appl Environ Microbiol 2008; 74:2153-2160; PMID:18245257; http://dx.doi.org/10.1128/AEM.02566-07
6. Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray K F, Christie DL, et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 2005; 115:e673-e680; PMID:15930195; http://dx.doi.org/10.1542/peds.2004-2236
7. Palermo MS, Exeni RA, Fernández GC. Hemolytic uremic syndrome: pathogenesis and update of interventions. Expert Rev Anti Infect Ther 2009; 7:697-707; PMID:19681698; http://dx.doi.org/10.1586/eri.09.49
8. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365:1073-1086; PMID:15781103
9. Bavaro M F. Escherichia coli O157: what every internist and gastroenterologist should know. Curr Gastroenterol Rep 2009; 11:301-306; PMID:19615306; http://dx.doi.org/10.1007/s11894-009-0044-0
10. Goldwater PN, Bettelheim KA. Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS). BMC Med 2012; 10:12; PMID:22300510; http://dx.doi.org/10.1186/1741-7015-10-12
11. Serna A, Boedeker EC. Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol 2008; 24:38-47; PMID:18043231; http://dx.doi.org/10.1097/MOG.0b013e3282f2dfb8
12. Scheiring J, Andreoli S P, Zimmerhackl LB. Treatment and outcome of Shiga-toxin-associated hemolytic ure-mic syndrome (HUS). Pediatr Nephrol 2008; 23:1749-1760; PMID:18704506; http://dx.doi.org/10.1007/s00467-008-0935-6f
13. Zimmerhackl LB., E. coli, antibiotics, and the hemolyt-ic-uremic syndrome. N Engl J Med 2000; 342:1990-1991; PMID:10874069; http://dx.doi.org/10.1056/NEJM200006293422611
14. Karch H, Schmidt H, Janetzki-Mittmann C, Scheef J, Kröger M. Shiga toxins even when different are encoded at identical positions in the genomes of related temperate bacteriophages. Mol Gen Genet 1999; 262:600-607; PMID:10628842; http://dx.doi.org/10.1007/s004380051122
15. Matsushiro A, Sato K, Miyamoto H, Yamamura T, Honda T. Induction of prophages of enterohemor-rhagic Escherichia coli O157:H7 with norfloxacin. J Bacteriol 1999; 181:2257-60; PMID:10094706
16. Wagner PL, Livny J, Neely MN, Acheson DW, Friedman DI, Waldor MK. Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. Mol Microbiol 2002; 44:957-70; PMID:12010491; http://dx.doi.org/10.1046/j.1365-2958.2002.02950.x
17. Rahal EA, Kazzi N, Nassar FJ, Matar GM. Escherichia coli O157:H7-Clinical aspects and novel treatment approaches. Front Cell Infect Microbiol 2012; 2:138; PMID:23162800; http://dx.doi.org/10.3389/fcimb.2012.00138
18. Safdar N, Said A, Gangnon RE, Maki DG. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA 2002; 288:996-1001; PMID:12190370; http://dx.doi.org/10.1001/jama.288.8.996
19. Slutsker L, Altekruse S F, Swerdlow DL. Foodborne diseases. Emerging pathogens and trends. Infect Dis Clin North Am 1998; 12:199-216; PMID:9494839; http://dx.doi.org/10.1016/S0891-5520(05)70418-9
20. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000; 342:1930-1936; PMID:10874060; http://dx.doi.org/10.1056/NEJM200006293422601
21. Wong CS, Mooney JC, Brandt JR, Staples AO, Jelacic S, Boster DR, et al. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis 2012; 55:33-41; PMID:22431799; http://dx.doi.org/10.1093/cid/cis299
22. Corogeanu D, Willmes R, Wolke M, Plum G, Utermöhlen O, Krönke M. Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak. BMC Microbiol 2012; 12:160; PMID:22853739; http://dx.doi.org/10.1186/1471-2180-12-160
23. Geerdes-Fenge H F, Löbermann M, Nürnberg M, Fritzsche C, Koball S, Henschel J, et al. Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea. Infection 2013; In press; PMID:23292662; http://dx.doi.org/10.1007/s15010-012-0387-6
24. Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, et al.; EHEC-HUS consortium. Validation of treatment strategies for entero-haemorrhagic Escherichia coli O104:H4 induced hae-molytic uraemic syndrome: case-control study. BMJ 2012; 345:e4565; PMID:22815429; http://dx.doi.org/10.1136/bmj.e4565
25. Dolgin E. As E. coli continues to claim lives, new approaches offer hope. Nat Med 2011; 17:755; PMID:21738132; http://dx.doi.org/10.1038/nm0711-755
26. Lino M, Kus J V, Tran SL, Naqvi Z, Binnington B, Goodman SD, et al. A novel antimicrobial pep-tide significantly enhances acid-induced killing of Shiga toxin-producing Escherichia coli O157 and non-O157 serotypes. Microbiology 2011; 157:1768-1775; PMID:21454368; http://dx.doi.org/10.1099/mic.0.047365-0
27. Stearns-Kurosawa DJ, Collins V, Freeman S, Debord D, Nishikawa K, Oh SY, et al. Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide. Pediatr Nephrol 2011; 26:2031-2039; PMID:21603905; http://dx.doi.org/10.1007/s00467-011-1913-y
28. Silberstein C, Lucero MS, Zotta E, Copeland D P, Lingyun L, Repetto HA, et al. A glucosylceramide synthase inhibitor protects rats against the cytotoxic effects of shiga toxin 2. Pediatr Res 2011; 69:390-394; PMID:21270676; http://dx.doi.org/10.1203/PDR.0b013e318211dd57
29. Crane JK, Byrd I W, Boedeker EC. Virulence inhibition by zinc in shiga-toxigenic Escherichia coli. Infect Immun 2011; 79:1696-1705; PMID:21245267; http://dx.doi.org/10.1128/IAI.01099-10
30. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between idiopathic hemo-lytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985; 151:775-782; PMID:3886804; http://dx.doi.org/10.1093/infdis/151.5.775
31. O'Brien AD, Lively TA, Chen ME, Rothman SW, Formal SB. Escherichia coli O157:H7 strains associated with hemorrhagic colitis in the United States produce a shigella dysenteriae 1 (shiga)-like cytotoxin. Lancet 1983; 321:702; http://dx.doi.org/10.1016/S0140-6736(83)91987-6
32. O'Brien AD, Tesh VL, Donohue-Rolfe A, Jackson M P, Olsnes S, Sandvig K, et al. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogen-esis. Curr Top Microbiol Immunol 1992; 180:65-94; PMID:1324134; http://dx.doi.org/10.1007/978-3-642-77238-2_4
33. Lingwood CA, Law H, Richardson S, Petric M, Brunton JL, De Grandis S, et al. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem 1987; 262:8834-8839; PMID:3298243
34. Waddell T, Head S, Petric M, Cohen A, Lingwood CA. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem Biophys Res Commun 1988; 152:674-679; PMID:3284526; http://dx.doi.org/10.1016/S0006-291X(88)80091-3
35. Bergan J, Dyve Lingelem AB, Simm R, Skotland T, Sandvig K. Shiga toxins. Toxicon 2012; 60:1085-1107; PMID:22960449; http://dx.doi.org/10.1016/j.toxicon.2012.07.016
36. Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukary-otic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 1988; 171:45-50; PMID:3276522; http://dx.doi.org/10.1111/j.1432-1033.1988.tb13756.x
37. Williams JM, Boyd B, Nutikka A, Lingwood CA, Barnett Foster DE, Milford DV, et al. A comparison of the effects of verocytotoxin-1 on primary human renal cell cultures. Toxicol Lett 1999; 105:47-57; PMID:10092056; http://dx.doi.org/10.1016/S0378-4274(98)00383-X
38. Frankel G, Lider O, Hershkoviz R, Mould A P, Kachalsky SG, Candy DCA, et al. The cell-binding domain of intimin from enteropathogenic Escherichia coli binds to beta1 integrins. J Biol Chem 1996; 271:20359-20364; PMID:8702771; http://dx.doi.org/10.1074/jbc.271.34.20359
39. McKee ML, Melton-Celsa AR, Moxley RA, Francis DH, O'Brien AD. Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobi-otic pig intestine and to adhere to HEp-2 cells. Infect Immun 1995; 63:3739-44; PMID:7642319
40. Sinclair J F, O'Brien AD. Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7. J Biol Chem 2002; 277:2876-2885; PMID:11704679; http://dx.doi.org/10.1074/jbc.M110230200
41. Jerse AE, Yu J, Tall BD, Kaper JB. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A 1990; 87:7839-7843; PMID:2172966; http://dx.doi.org/10.1073/pnas.87.20.7839
42. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 1997; 91:511-520; PMID:9390560; http://dx.doi.org/10.1016/S0092-8674(00)80437-7
43. Dytoc M T, Ismaili A, Philpott DJ, Soni R, Brunton JL, Sherman PM. Distinct binding properties of eaeA-negative verocytotoxin-producing Escherichia coli of serotype O113:H21. Infect Immun 1994; 62:3494-3505; PMID:7518809
44. Torres AG, Zhou X, Kaper JB. Adherence of diarrhea-genic Escherichia coli strains to epithelial cells. Infect Immun 2005; 73:18-29; PMID:15618137; http://dx.doi.org/10.1128/IAI.73.1.18-29.2005
45. Johnson JR, Jelacic S, Schoening LM, Clabots C, Shaikh N, Mobley HLT, et al. The IrgA homo-logue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection. Infect Immun 2005; 73:965-971; PMID:15664939; http://dx.doi.org/10.1128/IAI.73.2.965-971.2005
46. Tatsuno I, Horie M, Abe H, Miki T, Makino K, Shinagawa H, et al. Toxb gene on pO157 of entero-hemorrhagic Escherichia coli O157:H7 is required for full epithelial cell adherence phenotype. Infect Immun 2001; 69:6660-6669; PMID:11598035; http://dx.doi.org/10.1128/IAI.69.11.6660-6669.2001
47. Brunder W, Khan AS, Hacker J, Karch H. Novel type of fimbriae encoded by the large plasmid of sorbitol-fermenting enterohemorrhagic Escherichia coli O157:H(-). Infect Immun 2001; 69:4447-57; PMID:11401985; http://dx.doi.org/10.1128/IAI.69.7.4447-4457.2001
48. Low AS, Holden N, Rosser T, Roe AJ, Constantinidou C, Hobman JL, et al. Analysis of fimbrial gene clusters and their expression in enterohaemorrhagic Escherichia coli O157:H7. Environ Microbiol 2006; 8:1033-1047; PMID:16689724; http://dx.doi.org/10.1111/j.1462-2920.2006.00995.x
49. Low AS, Dziva F, Torres AG, Martinez JL, Rosser T, Naylor S, et al. Cloning, expression, and characterization of fimbrial operon F9 from enterohem-orrhagic Escherichia coli O157:H7. Infect Immun 2006; 74:2233-2244; PMID:16552054; http://dx.doi.org/10.1128/IAI.74.4.2233-2244.2006
50. Xicohtencatl-Cortes J, Monteiro-Neto V, Ledesma MA, Jordan DM, Francetic O, Kaper JB, et al. Intestinal adherence associated with type IV pili of enterohemorrhagic Escherichia coli O157:H7. J Clin Invest 2007; 117:3519-3529; PMID:17948128; http://dx.doi.org/10.1172/JCI30727
51. Xicohtencatl-Cortes J, Monteiro-Neto V, Saldaña Z, Ledesma MA, Puente JL, Girón JA. The type 4 pili of enterohemorrhagic Escherichia coli O157:H7 are multipurpose structures with pathogenic attributes. J Bacteriol 2009; 191:411-421; PMID:18952791; http://dx.doi.org/10.1128/JB.01306-08
52. Rendón MA, Saldaña Z, Erdem AL, Monteiro-Neto V, Vázquez A, Kaper JB, et al. Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization. Proc Natl Acad Sci U S A 2007; 104:10637-10642; PMID:17563352; http://dx.doi.org/10.1073/pnas.0704104104
53. Martínez-Santos VI, Medrano-López A, Saldaña Z, Girón JA, Puente JL. Transcriptional regulation of the ecp operon by EcpR, IHF, and H-NS in attaching and effacing Escherichia coli. J Bacteriol 2012; 194:5020-5033; PMID:22797761; http://dx.doi.org/10.1128/JB.00915-12
54. Erdem AL, Avelino F, Xicohtencatl-Cortes J, Girón JA. Host protein binding and adhesive properties of H6 and H7 flagella of attaching and effacing Escherichia coli. J Bacteriol 2007; 189:7426-7435; PMID:17693516; http://dx.doi.org/10.1128/JB.00464-07
55. Robinson CM, Sinclair J F, Smith MJ, O'Brien AD. Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc Natl Acad Sci U S A 2006; 103:9667-9672; PMID:16766659; http://dx.doi.org/10.1073/pnas.0602359103
56. Barnett Foster D, Abul-Milh M, Huesca M, Lingwood CA. Enterohemorrhagic Escherichia coli induces apop-tosis which augments bacterial binding and phos-phatidylethanolamine exposure on the plasma membrane outer leaflet. Infect Immun 2000; 68:3108-3115; PMID:10816451; http://dx.doi.org/10.1128/IAI.68.6.3108-3115.2000
57. Tobe T, Beatson SA, Taniguchi H, Abe H, Bailey CM, Fivian A, et al. An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci U S A 2006; 103:14941-14946; PMID:16990433; http://dx.doi.org/10.1073/pnas.0604891103
58. Frankel G, Phillips AD. Attaching effacing Escherichia coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal. Cell Microbiol 2008; 10:549-556; PMID:18053003; http://dx.doi.org/10.1111/j.1462-5822.2007.01103.x
59. Campellone KG, Roe AJ, Løbner-Olesen A, Murphy KC, Magoun L, Brady MJ, et al. Increased adherence and actin pedestal formation by dam-deficient enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol 2007; 63:1468-1481; PMID:17302821; http://dx.doi.org/10.1111/j.1365-2958.2007.05602.x
60. Ritchie JM, Waldor MK. The locus of enterocyte effacement-encoded effector proteins all promote enterohemorrhagic Escherichia coli pathogenicity in infant rabbits. Infect Immun 2005; 73:1466-1474; PMID:15731044; http://dx.doi.org/10.1128/IAI.73.3.1466-1474.2005
61. Abe H, Tatsuno I, Tobe T, Okutani A, Sasakawa C. Bicarbonate ion stimulates the expression of locus of enterocyte effacement-encoded genes in enterohem-orrhagic Escherichia coli O157:H7. Infect Immun 2002; 70:3500-3509; PMID:12065489; http://dx.doi.org/10.1128/IAI.70.7.3500-3509.2002
62. Nakanishi N, Abe H, Ogura Y, Hayashi T, Tashiro K, Kuhara S, et al. Ppgpp with DksA controls gene expression in the locus of enterocyte effacement (LEE) pathogenicity island of enterohaemorrhagic Escherichia coli through activation of two virulence regulatory genes. Mol Microbiol 2006; 61:194-205; PMID:16824105; http://dx.doi.org/10.1111/j.1365-2958.2006.05217.x
63. Sperandio V, Li CC, Kaper JB. Quorum-sensing Escherichia coli regulator A: a regulator of the LysR family involved in the regulation of the locus of enterocyte effacement pathogenicity island in entero-hemorrhagic E. coli. Infect Immun 2002; 70:3085-3093; PMID:12011002; http://dx.doi.org/10.1128/IAI.70.6.3085-3093.2002
64. Rosenshine I, Ruschkowski S, Finlay BB. Expression of attaching/effacing activity by enteropathogenic Escherichia coli depends on growth phase, temperature, and protein synthesis upon contact with epithelial cells. Infect Immun 1996; 64:966-973; PMID:8641808
65. Jandu N, Ho NK, Donato KA, Karmali MA, Mascarenhas M, Duffy S P, et al. Enterohemorrhagic Escherichia coli O157:H7 gene expression profiling in response to growth in the presence of host epithelia. PLoS One 2009; 4:e4889; PMID:19293938; http://dx.doi.org/10.1371/journal.pone.0004889
66. House B, Kus J V, Prayitno N, Mair R, Que L, Chingcuanco F, et al. Acid-stress-induced changes in enterohaemorrhagic Escherichia coli O157: H7 virulence. Microbiology 2009; 155:2907-2918; PMID:19497950; http://dx.doi.org/10.1099/mic.0.025171-0
67. Carruthers MD, Minion C. Transcriptome analysis of Escherichia coli O157:H7 EDL933 during heat shock. FEMS Microbiol Lett 2009; 295:96-102; PMID:19473256; http://dx.doi.org/10.1111/j.1574-6968.2009.01587.x
68. Gyles CL. Relevance in pathogenesis research. Vet Microbiol 2011; 153:2-12; PMID:21592684; http://dx.doi.org/10.1016/j.vetmic.2011.04.020
69. Kus JV, Gebremedhin A, Dang V, Tran SL, Serbanescu A, Barnett Foster D. Bile salts induce resistance to poly-myxin in enterohemorrhagic Escherichia coli O157:H7. J Bacteriol 2011; 193:4509-4515; PMID:21725004; http://dx.doi.org/10.1128/JB.00200-11
70. Kendall MM, Gruber CC, Parker CT, Sperandio V. Ethanolamine controls expression of genes encoding components involved in interking-dom signaling and virulence in enterohemorrhagic Escherichia coli O157:H7. MBio 2012; 3:e00050-e00112; PMID:22589288; http://dx.doi.org/10.1128/mBio.00050-12
71. Pacheco AR, Sperandio V. Shiga toxin in entero-hemorrhagic E.coli: regulation and novel anti-virulence strategies. Front Cell Infect Microbiol 2012; 2:81; PMID:22919672; http://dx.doi.org/10.3389/fcimb.2012.00081
72. Marteyn B, Gazi A, Sansonetti P. Shigella: a model of virulence regulation in vivo. Gut Microbes 2012; 3:104-120; PMID:22356862; http://dx.doi.org/10.4161/gmic.19325
73. Foster JW. Escherichia coli acid resistance: tales of an amateur acidophile. Nat Rev Microbiol 2004; 2:898-907; PMID:15494746; http://dx.doi.org/10.1038/nrmicro1021
74. Lin J, Smith M P, Chapin KC, Baik HS, Bennett GN, Foster J W. Mechanisms of acid resistance in enterohe-morrhagic Escherichia coli. Appl Environ Microbiol 1996; 62:3094-3100; PMID:8795195
75. Price SB, Wright JC, DeGraves FJ, Castanie-Cornet M P, Foster J W. Acid resistance systems required for survival of Escherichia coli O157:H7 in the bovine gastrointestinal tract and in apple cider are different. Appl Environ Microbiol 2004; 70:4792-4799; PMID:15294816; http://dx.doi.org/10.1128/AEM.70.8.4792-4799.2004
76. Kailasan Vanaja S, Bergholz TM, Whittam TS. Characterization of the Escherichia coli O157:H7 Sakai GadE regulon. J Bacteriol 2009; 191:1868-77; PMID:19114477; http://dx.doi.org/10.1128/JB.01481-08
77. Laaberki MH, Janabi N, Oswald E, Repoila F. Concert of regulators to switch on LEE expression in entero-hemorrhagic Escherichia coli O157:H7: interplay between Ler, GrlA, HNS and RpoS. Int J Med Microbiol 2006; 296:197-210; PMID:16618552; http://dx.doi.org/10.1016/j.ijmm.2006.02.017
78. Chingcuanco F, Yu Y, Kus JV, Que L, Lackraj T, Lévesque CM, et al. Identification of a novel adhesin involved in acid-induced adhesion of enterohaemor-rhagic Escherichia coli O157: H7. Microbiology 2012; 158:2399-2407; PMID:22767547; http://dx.doi.org/10.1099/mic.0.056374-0
79. Nguyen Y, Sperandio V. Enterohemorrhagic E. coli (EHEC) pathogenesis. Front Cell Infect Microbiol 2012; 2:90; PMID:22919681; http://dx.doi.org/10.3389/fcimb.2012.00090
80. Hughes DT, Terekhova DA, Liou L, Hovde CJ, Sahl J W, Patankar AV, et al. Chemical sensing in mammalian host-bacterial commensal associations. Proc Natl Acad Sci U S A 2010; 107:9831-9836; PMID:20457895; http://dx.doi.org/10.1073/pnas.1002551107
81. Kanamaru K, Kanamaru K, Tatsuno I, Tobe T, Sasakawa C. SdiA, an Escherichia coli homologue of quorum-sensing regulators, controls the expression of virulence factors in enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol 2000; 38:805-816; PMID:11115115; http://dx.doi.org/10.1046/j.1365-2958.2000.02171.x
82. Lacroix FJ, Cloeckaert A, Grépinet O, Pinault C, Popoff MY, Waxin H, et al. Salmonella typhimurium acrB-like gene: identification and role in resistance to biliary salts and detergents and in murine infection. FEMS Microbiol Lett 1996; 135:161-167; PMID:8595853; http://dx.doi.org/10.1111/j.1574-6968.1996.tb07983.x
83. Prouty AM, Brodsky IE, Manos J, Belas R, Falkow S, Gunn JS. Transcriptional regulation of Salmonella enterica serovar Typhimurium genes by bile. FEMS Immunol Med Microbiol 2004; 41:177-185; PMID:15145463; http://dx.doi.org/10.1016/j.fem-sim.2004.03.002
84. Thanassi DG, Cheng LW, Nikaido H. Active efflux of bile salts by Escherichia coli. J Bacteriol 1997; 179:2512-2518; PMID:9098046
85. Cerda-Maira FA, Ringelberg CS, Taylor RK. The bile response repressor BreR regulates expression of the Vibrio cholerae breAB efflux system operon. J Bacteriol 2008; 190:7441-7452; PMID:18776020; http://dx.doi.org/10.1128/JB.00584-08
86. Wibbenmeyer JA, Provenzano D, Landry C F, Klose KE, Delcour AH. Vibrio cholerae OmpU and OmpT porins are differentially affected by bile. Infect Immun 2002; 70:121-126; PMID:11748172; http://dx.doi.org/10.1128/IAI.70.1.121-126.2002
87. de Jesus MC, Urban AA, Marasigan ME, Barnett Foster DE. Acid and bile-salt stress of enteropatho-genic Escherichia coli enhances adhesion to epithelial cells and alters glycolipid receptor binding specificity. J Infect Dis 2005; 192:1430-1440; PMID:16170762; http://dx.doi.org/10.1086/462422
88. Torres AG, Tutt CB, Duval L, Popov V, Nasr AB, Michalski J, et al. Bile salts induce expression of the afimbrial LDA adhesin of atypical enteropathogenic Escherichia coli. Cell Microbiol 2007; 9:1039-1049; PMID:17381433; http://dx.doi.org/10.1111/j.1462-5822.2006.00850.x
89. Gunn JS. Mechanisms of bacterial resistance and response to bile. Microbes Infect 2000; 2:907-913; PMID:10962274; http://dx.doi.org/10.1016/S1286-4579(00)00392-0
90. Prouty AM, Gunn JS. Salmonella enterica serovar typhimurium invasion is repressed in the presence of bile. Infect Immun 2000; 68:6763-6769; PMID:11083793; http://dx.doi.org/10.1128/IAI.68.12.6763-6769.2000
91. Hung D T, Zhu J, Sturtevant D, Mekalanos JJ. Bile acids stimulate biofilm formation in Vibrio cholerae. Mol Microbiol 2006; 59:193-201; PMID:16359328; http://dx.doi.org/10.1111/j.1365-2958.2005.04846.x
92. Kristoffersen SM, Ravnum S, Tourasse NJ, Økstad OA, Kolstø AB, Davies W. Low concentrations of bile salts induce stress responses and reduce motility in Bacillus cereus ATCC 14579 [corrected]. J Bacteriol 2007; 189:5302-5313; PMID:17496091; http://dx.doi.org/10.1128/JB.00239-07
93. Malik-Kale P, Parker C T, Konkel ME. Culture of Campylobacter jejuni with sodium deoxycho-late induces virulence gene expression. J Bacteriol 2008; 190:2286-2297; PMID:18223090; http://dx.doi.org/10.1128/JB.01736-07
94. Prouty AM, Brodsky IE, Falkow S, Gunn JS. Bile-salt-mediated induction of antimicrobial and bile resistance in Salmonella typhimurium. Microbiology 2004; 150:775-783; PMID:15073288; http://dx.doi.org/10.1099/mic.0.26769-0
95. Pumbwe L, Skilbeck CA, Nakano V, Avila-Campos MJ, Piazza RM, Wexler HM. Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis. Microb Pathog 2007; 43:78-87; PMID:17524609; http://dx.doi.org/10.1016/j.mic-path.2007.04.002
96. Rychlik I, Barrow PA. Salmonella stress management and its relevance to behaviour during intestinal colonisation and infection. FEMS Microbiol Rev 2005; 29:1021-1040; PMID:16023758; http://dx.doi.org/10.1016/j.femsre.2005.03.005
97. van Velkinburgh JC, Gunn JS. PhoP-PhoQ-regulated loci are required for enhanced bile resistance in Salmonella spp. Infect Immun 1999; 67:1614-1622; PMID:10084994
98. Nikaido E, Yamaguchi A, Nishino K. AcrAB multi-drug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals. J Biol Chem 2008; 283:24245-242053; PMID:18577510; http://dx.doi.org/10.1074/jbc.M804544200
99. Moskowitz SM, Ernst RK, Miller SI. PmrAB, a two-component regulatory system of Pseudomonas aerugi-nosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J Bacteriol 2004; 186:575-579; PMID:14702327; http://dx.doi.org/10.1128/JB.186.2.575-579.2004
100. McPhee JB, Lewenza S, Hancock RE. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol Microbiol 2003; 50:205-217; PMID:14507375; http://dx.doi.org/10.1046/j.1365-2958.2003.03673.x
101. Garsin DA. Ethanolamine: a signal to commence a host-associated lifestyle? MBio 2012; 3:e00172-e00212; PMID:22761393; http://dx.doi.org/10.1128/mBio.00172-12
102. Lawhon SD, Frye JG, Suyemoto M, Porwollik S, McClelland M, Altier C. Global regulation by CsrA in Salmonella typhimurium. Mol Microbiol 2003; 48:1633-1645; PMID:12791144; http://dx.doi.org/10.1046/j.1365-2958.2003.03535.x
103. Kelly A, Goldberg MD, Carroll RK, Danino V, Hinton JC, Dorman CJ. A global role for Fis in the transcriptional control of metabolism and type III secretion in Salmonella enterica serovar Typhimurium. Microbiology 2004; 150:2037-2053; PMID:15256548; http://dx.doi.org/10.1099/mic.0.27209-0
104. Barnett Foster DE, Philpott D, Abul-Milh M, Huesca M, Sherman PM, Lingwood CA. Phosphatidylethanolamine recognition promotes enteropathogenic E. coli and enterohemorrhagic E. coli host cell attachment. Microb Pathog 1999; 27:289-301; PMID:10545256; http://dx.doi.org/10.1006/mpat.1999.0305
105. Wu Y, Lau B, Smith S, Troyan K, Barnett Foster DE. Enteropathogenic Escherichia coli infection triggers host phospholipid metabolism perturbations. Infect Immun 2004; 72:6764-6772; PMID:15557596; http://dx.doi.org/10.1128/IAI.72.12.6764-6772.2004
106. Abul-Milh M, Wu Y, Lau B, Lingwood CA, Barnett Foster DE. Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili. Infect Immun 2001; 69:7356-7364; PMID:11705908; http://dx.doi.org/10.1128/IAI.69.12.7356-7364.2001
107. Khursigara C, Abul-Milh M, Lau B, Giron J, Lingwood CA, Barnett Foster DE. Enteropathogenic Escherichia coli virulence factor bundle-forming pilus has a binding specificity for phosphatidylethanolamine. Infect Immun 2001; 69:6573-6579; PMID:11598024; http://dx.doi.org/10.1128/IAI.69.11.6573-6579.2001
108. Macfarlane GT, Gibson GR, Cummings JH. Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 1992; 72:57-64; PMID:1541601
109. Cummings JH, Pomare EW, Branch WJ, Naylor C P, Macfarlane G T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987; 28:1221-1227; PMID:3678950; http://dx.doi.org/10.1136/gut.28.10.1221
110. Argenzio RA, Southworth M, Stevens CE. Sites of organic acid production and absorption in the equine gastrointestinal tract. Am J Physiol 1974; 226:1043-1050; PMID:4824856
111. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006; 40:235-243; PMID:16633129; http://dx.doi.org/10.1097/00004836-200603000-00015
112. Nakanishi N, Tashiro K, Kuhara S, Hayashi T, Sugimoto N, Tobe T. Regulation of virulence by butyr-ate sensing in enterohaemorrhagic Escherichia coli. Microbiology 2009; 155:521-530; PMID:19202100; http://dx.doi.org/10.1099/mic.0.023499-0
113. Tobe T, Nakanishi N, Sugimoto N. Activation of motility by sensing short-chain fatty acids via two steps in a flagellar gene regulatory cascade in enterohemor-rhagic Escherichia coli. Infect Immun 2011; 79:1016-1024; PMID:21149585; http://dx.doi.org/10.1128/IAI.00927-10
114. Herold S, Paton JC, Srimanote P, Paton AW. Differential effects of short-chain fatty acids and iron on expression of iha in Shiga-toxigenic Escherichia coli. Microbiology 2009; 155:3554-3563; PMID:19684070; http://dx.doi.org/10.1099/mic.0.029454-0
115. Clarke MB, Hughes DT, Zhu C, Boedeker EC, Sperandio V. The QseC sensor kinase: a bacterial adrenergic receptor. Proc Natl Acad Sci U S A 2006; 103:10420-10425; PMID:16803956; http://dx.doi.org/10.1073/pnas.0604343103
116. Reading NC, Torres AG, Kendall MM, Hughes DT, Yamamoto K, Sperandio V. A novel two-component signaling system that activates transcription of an enterohemorrhagic Escherichia coli effector involved in remodeling of host actin. J Bacteriol 2007; 189:2468-2476; PMID:17220220; http://dx.doi.org/10.1128/JB.01848-06
117. Njoroge J, Sperandio V. Enterohemorrhagic Escherichia coli virulence regulation by two bacterial adrenergic kinases, QseC and QseE. Infect Immun 2012; 80:688-703; PMID:22144490; http://dx.doi.org/10.1128/IAI.05921-11
118. de Sablet T, Chassard C, Bernalier-Donadille A, Vareille M, Gobert A P, Martin C. Human microbiota-secreted factors inhibit shiga toxin synthesis by enterohem-orrhagic Escherichia coli O157:H7. Infect Immun 2009; 77:783-790; PMID:19064636; http://dx.doi.org/10.1128/IAI.01048-08
119. Carey CM, Kostrzynska M, Ojha S, Thompson S. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. J Microbiol Methods 2008; 73:125-132; PMID:18328583; http://dx.doi.org/10.1016/j.mimet.2008.01.014
120. Liévin-Le Moal V, Servin AL. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev 2006; 19:315-337; PMID:16614252; http://dx.doi.org/10.1128/CMR.19.2.315-337.2006
121. Macfarlane S, Bahrami B, Macfarlane GT. Mucosal biofilm communities in the human intestinal tract. Adv Appl Microbiol 2011; 75:111-143; PMID:21807247; http://dx.doi.org/10.1016/B978-0-12-387046-9.00005-0
122. Bearson BL, Bearson SM. The role of the QseC quorum-sensing sensor kinase in colonization and nor-epinephrine-enhanced motility of Salmonella enterica serovar Typhimurium. Microb Pathog 2008; 44:271-278; PMID:17997077; http://dx.doi.org/10.1016/j.mic-path.2007.10.001
123. Nakano M, Takahashi A, Sakai Y, Nakaya Y. Modulation of pathogenicity with norepinephrine related to the type III secretion system of Vibrio parahaemolyticus. J Infect Dis 2007; 195:1353-1360; PMID:17397007; http://dx.doi.org/10.1086/513275
124. Lyte M, Arulanandam B, Nguyen K, Frank C, Erickson A, Francis D. Norepinephrine induced growth and expression of virulence associated factors in enterotoxi-genic and enterohemorrhagic strains of Escherichia coli. Adv Exp Med Biol 1997; 412:331-339; PMID:9192038
125. Wang X, Wang Q, Yang M, Xiao J, Liu Q, Wu H, et al. QseBC controls flagellar motility, fimbrial hemagglutination and intracellular virulence in fish pathogen Edwardsiella tarda. Fish Shellfish Immunol 2011; 30:944-953; PMID:21288493; http://dx.doi.org/10.1016/j.fsi.2011.01.019
126. Hughes DT, Clarke MB, Yamamoto K, Rasko DA, Sperandio V. The QseC adrenergic signaling cascade in Enterohemorrhagic E. coli (EHEC). PLoS Pathog 2009; 5:e1000553; PMID:19696934; http://dx.doi.org/10.1371/journal.ppat.1000553
127. Baxt LA, Goldberg MB. Anaerobic environment of the intestine primes pathogenic Shigella for infection. Expert Rev Anti Infect Ther 2010; 8:1225-1229; PMID:21073287; http://dx.doi.org/10.1586/eri.10.123
128. Marteyn B, West N P, Browning DF, Cole JA, Shaw JG, Palm F, et al. Modulation of Shigella virulence in response to available oxygen in vivo. Nature 2010; 465:355-358; PMID:20436458; http://dx.doi.org/10.1038/nature08970
129. Saldeña TA, Saraví FD, Hwang HJ, Cincunegui LM, Carra GE. Oxygen diffusive barriers of rat distal colon: role of subepithelial tissue, mucosa, and mucus gel layer. Dig Dis Sci 2000; 45:2108-2114; PMID:11215723; http://dx.doi.org/10.1023/A:1026411118033
130. Dibden D P, Green J. In vivo cycling of the Escherichia coli transcription factor FNR between active and inactive states. Microbiology 2005; 151:4063-4070; PMID:16339951; http://dx.doi.org/10.1099/mic.0.28253-0
131. Jones SA, Chowdhury FZ, Fabich AJ, Anderson A, Schreiner DM, House AL, et al. Respiration of Escherichia coli in the mouse intestine. Infect Immun 2007; 75:4891-4899; http://dx.doi.org/10.1128/IAI.00484-07; PMID:17698572
132. Alexeeva S, Hellingwerf KJ, Teixeira de Mattos MJ. Requirement of ArcA for redox regulation in Escherichia coli under microaerobic but not anaerobic or aerobic conditions. J Bacteriol 2003; 185:204-209; PMID:12486057; http://dx.doi.org/10.1128/JB.185.1.204-209.2003
133. Schüller S, Phillips AD. Microaerobic conditions enhance type III secretion and adherence of entero-haemorrhagic Escherichia coli to polarized human intestinal epithelial cells. Environ Microbiol 2010; 12:2426-2435; PMID:20406285; http://dx.doi.org/10.1111/j.1462-2920.2010.02216.x